Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection.
Peripheral nerve disorders are among the most common neurological complications of HIV disease. Distal sensory polyneuropathy (DSP) is the most common form of neuropathy in patients with AIDS and can be caused by diverse mechanisms, including infectious, metabolic, inflammatory, nutritional, and toxic factors. Antiretroviral agents may cause or contribute to HIV-related DSP. Recognition of peripheral neuropathy has become increasingly important as more patients receive nucleoside analogue agents for the treatment of HIV disease. It is crucial to correctly distinguish between the neuropathies caused by toxic effects of nucleoside analogues and those that are primarily related to underlying HIV disease, because timely diagnosis and proper treatment of peripheral neuropathies may allow the continuation of antiretroviral therapy as well as improve the quality of life. The identification and treatment of peripheral neuropathies associated with use of the nucleoside drugs zalcitabine (ddC), didanosine (ddI), and stavudine (d4T) are reviewed.
Simpson
D M
DM
Department of Neurology, Mount Sinai Medical Center, New York, NY 10029, USA.
Tagliati
M
M
D000818:Animals; D016049:Didanosine / Q000009:adverse effects; D015224:Dideoxynucleosides / Q000009:adverse effects*; D004195:Disease Models, Animal; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D018119:Stavudine / Q000009:adverse effects; D016047:Zalcitabine / Q000009:adverse effects
D015224:Dideoxynucleosides; D016047:Zalcitabine; D018119:Stavudine; D016049:Didanosine